nelarabine

Generic: nelarabine

Labeler: dr. reddy's laboratories, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name nelarabine
Generic Name nelarabine
Labeler dr. reddy's laboratories, inc.
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

nelarabine 5 mg/mL

Manufacturer
Dr. Reddy's Laboratories, Inc.

Identifiers & Regulatory

Product NDC 43598-142
Product ID 43598-142_8105c460-afd8-5eec-7857-c2e4e5b89fc3
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA216934
Listing Expiration 2026-12-31
Marketing Start 2023-01-09

Pharmacologic Class

Established (EPC)
nucleoside metabolic inhibitor [epc]
Mechanism of Action
nucleic acid synthesis inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 43598142
Hyphenated Format 43598-142

Supplemental Identifiers

RxCUI
603566
UPC
0343598142111 0343598142067
UNII
60158CV180
NUI
N0000000233 N0000175595

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name nelarabine (source: ndc)
Generic Name nelarabine (source: ndc)
Application Number ANDA216934 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 5 mg/mL
source: ndc
Packaging
  • 6 VIAL, SINGLE-DOSE in 1 CARTON (43598-142-06) / 50 mL in 1 VIAL, SINGLE-DOSE
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (43598-142-11) / 50 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (2)

Ingredients (1)

nelarabine (5 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "8105c460-afd8-5eec-7857-c2e4e5b89fc3", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0343598142111", "0343598142067"], "unii": ["60158CV180"], "rxcui": ["603566"], "spl_set_id": ["57275b05-f40f-7298-5a5e-93594bc41437"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Dr. Reddy's Laboratories, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "6 VIAL, SINGLE-DOSE in 1 CARTON (43598-142-06)  / 50 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "43598-142-06", "marketing_start_date": "20230109"}, {"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (43598-142-11)  / 50 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "43598-142-11", "marketing_start_date": "20230301"}], "brand_name": "Nelarabine", "product_id": "43598-142_8105c460-afd8-5eec-7857-c2e4e5b89fc3", "dosage_form": "INJECTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "43598-142", "generic_name": "Nelarabine", "labeler_name": "Dr. Reddy's Laboratories, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nelarabine", "active_ingredients": [{"name": "NELARABINE", "strength": "5 mg/mL"}], "application_number": "ANDA216934", "marketing_category": "ANDA", "marketing_start_date": "20230109", "listing_expiration_date": "20261231"}